Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Vaccines01:30

Cancer Vaccines

347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
Cancer Survival Analysis01:21

Cancer Survival Analysis

334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Tumor Immunotherapy01:27

Tumor Immunotherapy

493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Tumor Progression02:07

Tumor Progression

6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer02:18

Cancer

48.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Rare, Yet Targetable: New Perspectives on Ampullary Carcinomas.

International journal of molecular sciences·2026
Same author

Precision oncology in rare tumors: Have the orphans been adopted?

Med (New York, N.Y.)·2026
Same author

Personalized cancer vaccines and their integration with standard of care modalities.

Cancer treatment reviews·2026
Same author

Efficacy of Immune Checkpoint Inhibitors and Oncoviruses in Solid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry.

Journal for immunotherapy of cancer·2025
Same author

Biliary tract cancers: advances in diagnostic and management.

Exploration of targeted anti-tumor therapy·2025

相关实验视频

Updated: Jun 14, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

1.9K

个性化瘤学的进展

Hiba Mechahougui1, James Gutmans1, Gina Colarusso1

  • 1Oncology Department, Geneva University Hospital (HUG), 1205 Geneva, Switzerland.

Cancers
|August 29, 2024
PubMed
概括

下一代测序 (NGS) 推进了精确的癌症医学. 解释复杂的基因组数据和选择向治疗需要质量测试和临床判断,以改善患者的治疗结果.

关键词:
驱动器突变 驱动器突变致癌性改变 致癌性改变致癌的驱动因素个性化医疗是个性化的医疗.精准医学是一门精准医学.精确瘤学 精确瘤学

更多相关视频

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.0K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K

相关实验视频

Last Updated: Jun 14, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

1.9K
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.0K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K

科学领域:

  • 在瘤学瘤学.
  • 基因组学就是基因组学.
  • 翻译医学是一种翻译医学.

背景情况:

  • 下一代测序 (NGS) 已经将癌症护理转变为精准医学.
  • 向治疗和伴随诊断是这一转变的关键组成部分.
  • 解释广泛的基因突变数据是一个重大的临床挑战.

研究的目的:

  • 突出NGS对精确癌症治疗的影响.
  • 讨论针对性治疗和伴随性诊断的作用.
  • 解决解释基因组数据用于临床决策的挑战.

主要方法:

  • 审查下一代测序技术的进展.
  • 分析针对性治疗和伴随性诊断的整合.
  • 讨论复杂基因组资料的临床决策过程.

主要成果:

  • NGS促进了从特定器官到个性化癌症治疗策略的转变.
  • 伴随性诊断对于将疗法与分子变化相匹配至关重要.
  • 以质量为中心的基因组测试对于识别可操作的突变至关重要.

结论:

  • 解释复杂的基因组景观对于有效的癌症治疗选择至关重要.
  • 分子瘤板可以将基因组数据集成到临床试验中,以进行精细的个性化治疗.
  • 增强的基因组测试和临床判断对于改善精确瘤学患者的治疗结果至关重要.